Glipizide ER tablets are used to treat type 2 diabetes in patients, particularly in people whose diabetes cannot be controlled through diet alone. Glipizide ER tablets are the authorized generic product of Pfizer's Glucotrol XL® tablets. The product is acquired by Actavis from Andrx Pharma as part of a Federal Trade Commission ("FTC") divestiture requirement.  Actavis' product is AB rated to Glucotrol XL® tablets.

 

Glipizide ER tablets are available in 2.5mg, 5mg, and 10mg strengths.  Total annual sales of Glipizide ER tablets from all suppliers in the U.S. were approximately US$195 million for the twelve months ending June 2006 according to IMS Health.